Guidant Corporation

300 Boston Scientific Way, Marlborough, Massachusetts, United States

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 4

29.4%

Not Applicable

5.9%

Phase 2

5.9%

Trial Status Distribution

Completed

82.3%

Suspended

5.9%

Terminated

5.9%

Withdrawn

5.9%

Clinical Trials

Trials sponsored by this organization (17)

Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study

Completed

observational

Oct 2010120 participants

The 4-SITE Field Following Study (4-SITE FF)

Completed

observational

May 2009430 participants

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device

Not Applicable

Completed

interventional

Nov 2008263 participants

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following

Completed

observational

Feb 2008450 participants

PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)

Phase 2

Completed

interventional

Dec 200660 participants

REBEAT Resynchronisation and Beta-Blocker European Trial

Phase 4

Terminated

interventional

Apr 2006354 participants

Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

Completed

observational

Feb 2006600 participants

Canadian Registry of ICD Implant Testing Procedures

Completed

observational

Jan 2006261 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations